Literature DB >> 15757802

Epidemiology and natural history of hepatocellular carcinoma.

Katherine A McGlynn1, W Thomas London.   

Abstract

Hepatocellular carcinoma (HCC) is a major contributor to cancer incidence and mortality. There is a wide variation, however, in the global distribution of HCC. Eighty percent of the burden is borne by countries in Asia and sub-Saharan Africa. In most high-risk countries, principal risk factors include infection with hepatitis B virus and dietary exposure to aflatoxin B(1). In contrast, hepatitis C virus and alcohol consumption are more important risk factors in low-risk countries. In recent years, the incidence of HCC has decreased in some high-risk countries and increased in some low-risk countries. Reasons for both trends are not completely understood, but are likely related to public health efforts in Asia and the increase in hepatitis C virus infection in low-risk countries. Vaccination programs against hepatitis B virus will likely decrease the HCC rate even further in decades to come.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757802     DOI: 10.1016/j.bpg.2004.10.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  114 in total

1.  Socioeconomic status and hepatocellular carcinoma in the United States.

Authors:  Fatma M Shebl; David E Capo-Ramos; Barry I Graubard; Katherine A McGlynn; Sean F Altekruse
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-05       Impact factor: 4.254

2.  Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2.

Authors:  Qing-Hua Yin; Feng-Xiang Yan; Xu-Yu Zu; You-Hua Wu; Xiao-Ping Wu; Ming-Chu Liao; Shu-Wen Deng; Lei-Lan Yin; Ying-Zhi Zhuang
Journal:  Cytotechnology       Date:  2011-09-22       Impact factor: 2.058

3.  Policy alternatives for treatments for rare diseases.

Authors:  Abbas H Panju; Chaim M Bell
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

4.  From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways.

Authors:  Enzo Ierardi; Rosa Rosania; Mariangela Zotti; Floriana Giorgio; Simonetta Prencipe; Nicola Della Valle; Vincenzo De Francesco; Carmine Panella
Journal:  World J Gastrointest Oncol       Date:  2010-06-15

Review 5.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

6.  Antiproliferation and apoptosis induction of paeonol in HepG2 cells.

Authors:  Shu-Ping Xu; Guo-Ping Sun; Yu-Xian Shen; Wei Wei; Wan-Ren Peng; Hua Wang
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

7.  Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Authors:  Yi Shen; Harvey Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar Taddei; Karen Pawlish; Antoinette Stroup; Robert Brown; Zhanwei Wang; Wei Jia; Linda Wong; Susan T Mayne; Herbert Yu
Journal:  Cancer Causes Control       Date:  2020-02-14       Impact factor: 2.506

8.  Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.

Authors:  Shinji Sugahara; Hidetsugu Nakayama; Kuniaki Fukuda; Masashi Mizumoto; Mari Tokita; Masato Abei; Junichi Shoda; Yasushi Matsuzaki; Eriko Thono; Koji Tsuboi; Koichi Tokuuye
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

9.  miR-221 overexpression contributes to liver tumorigenesis.

Authors:  Pascal Pineau; Stefano Volinia; Katherine McJunkin; Agnès Marchio; Carlo Battiston; Benoît Terris; Vincenzo Mazzaferro; Scott W Lowe; Carlo M Croce; Anne Dejean
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

10.  Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells.

Authors:  En-Hua Xiao; Dong Guo; Du-Jun Bian
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.